C. H. J. Ford

1.5k total citations
37 papers, 893 citations indexed

About

C. H. J. Ford is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, C. H. J. Ford has authored 37 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Radiology, Nuclear Medicine and Imaging, 19 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in C. H. J. Ford's work include Monoclonal and Polyclonal Antibodies Research (19 papers), Radiopharmaceutical Chemistry and Applications (11 papers) and Glycosylation and Glycoproteins Research (10 papers). C. H. J. Ford is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (19 papers), Radiopharmaceutical Chemistry and Applications (11 papers) and Glycosylation and Glycoproteins Research (10 papers). C. H. J. Ford collaborates with scholars based in Canada, United Kingdom and Kuwait. C. H. J. Ford's co-authors include C.E. Newman, C S Woodhouse, Maie Al‐Bader, Issam M. Francis, Bushra Al‐Ayadhy, Gervais Bérubé, Vernon J. Richardson, M. W. Elves, G. F. Rowland and R.G. Simmonds and has published in prestigious journals such as British Journal of Cancer, International Journal of Cancer and Thorax.

In The Last Decade

C. H. J. Ford

37 papers receiving 840 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. H. J. Ford Canada 17 347 305 298 148 105 37 893
H.H. Sedlacek Germany 20 596 1.7× 287 0.9× 485 1.6× 225 1.5× 82 0.8× 69 1.3k
Jen Wei Chiao United States 20 760 2.2× 116 0.4× 205 0.7× 317 2.1× 80 0.8× 70 1.3k
Bertil Björklund Sweden 16 399 1.1× 150 0.5× 201 0.7× 139 0.9× 50 0.5× 53 971
William B. McCombs United States 10 585 1.7× 119 0.4× 418 1.4× 129 0.9× 111 1.1× 15 1.1k
Bing Zheng China 21 364 1.0× 221 0.7× 343 1.2× 171 1.2× 61 0.6× 51 1.1k
Huili Lu China 20 481 1.4× 222 0.7× 316 1.1× 242 1.6× 103 1.0× 65 1.0k
Jenny J. L. Ho United States 19 855 2.5× 290 1.0× 488 1.6× 284 1.9× 59 0.6× 40 1.3k
Carolyn Lyftogt United States 11 631 1.8× 140 0.5× 256 0.9× 263 1.8× 70 0.7× 16 1.1k
Marc Nasoff United States 16 638 1.8× 211 0.7× 179 0.6× 166 1.1× 133 1.3× 34 1.4k
Krzysztof Grzegorzewski United States 15 312 0.9× 88 0.3× 214 0.7× 370 2.5× 49 0.5× 34 862

Countries citing papers authored by C. H. J. Ford

Since Specialization
Citations

This map shows the geographic impact of C. H. J. Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. H. J. Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. H. J. Ford more than expected).

Fields of papers citing papers by C. H. J. Ford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. H. J. Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. H. J. Ford. The network helps show where C. H. J. Ford may publish in the future.

Co-authorship network of co-authors of C. H. J. Ford

This figure shows the co-authorship network connecting the top 25 collaborators of C. H. J. Ford. A scholar is included among the top collaborators of C. H. J. Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. H. J. Ford. C. H. J. Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Bader, Maie, C. H. J. Ford, Bushra Al‐Ayadhy, & Issam M. Francis. (2011). Analysis of estrogen receptor isoforms and variants in breast cancer cell lines. Experimental and Therapeutic Medicine. 2(3). 537–544. 80 indexed citations
2.
Stavri, Michael, C. H. J. Ford, Franz Bučar, et al.. (2004). Bioactive constituents of Artemisia monosperma. Phytochemistry. 66(2). 233–239. 60 indexed citations
3.
Ford, C. H. J., et al.. (2001). Affinity purification of novel bispecific antibodies recognising carcinoembryonic antigen and doxorubicin. Journal of Chromatography B Biomedical Sciences and Applications. 754(2). 427–435. 5 indexed citations
4.
Ford, C. H. J., et al.. (2001). Bispecific antibody targeting of doxorubicin to carcinoembryonic antigen-expressing colon cancer cell linesin vitro andin vivo. International Journal of Cancer. 92(6). 851–855. 20 indexed citations
5.
Bérubé, Gervais, et al.. (1995). Conjugation of doxorubicin to monoclonal anti-carcinoembryonic antigen antibody via novel thiol-directed cross-linking reagents. Bioorganic & Medicinal Chemistry. 3(10). 1299–1304. 24 indexed citations
6.
Bérubé, Gervais, et al.. (1995). Novel doxorubicin-monoclonal anti-carcinoembryonic antigen antibody immunoconjugate activity in vitro. Bioorganic & Medicinal Chemistry. 3(10). 1305–1312. 30 indexed citations
7.
8.
Ford, C. H. J., et al.. (1992). Toxicity of 3'-deamino-3'-(3-cyano-4-morpholinyl) doxorubicin and doxorubicin in nude mice bearing human tumour xenografts.. PubMed. 11(5). 1855–62. 1 indexed citations
9.
Ford, C. H. J., Vernon J. Richardson, & Vijay Reddy. (1990). Antibody mediated targeting of radioisotopes, drugs and toxins in diagnosis and treatment. The Indian Journal of Pediatrics. 57(1). 29–46. 3 indexed citations
10.
Richardson, Vernon J., et al.. (1989). Doxorubicin-Anti-carcinoembryonic antigen immunoconjugate activity in vitro. European Journal of Cancer and Clinical Oncology. 25(4). 633–640. 9 indexed citations
11.
Ford, C. H. J., Fiona MacDonald, J A Griffin, Paul Life, & Stephen Bartlett. (1987). Immunoadsorbent Purification of Carcinoembryonic Antigen using a Monoclonal Antibody: A Direct Comparison with a Conventional Method. Tumor Biology. 8(5). 241–250. 4 indexed citations
12.
Ford, C. H. J., et al.. (1985). Immunocytochemical Investigation of Carcinoembryonic Antigen Expression in Neuroblastoma with Monoclonal and Polyclonal Antibodies. Pediatric Research. 19(4). 385–388. 4 indexed citations
13.
Wilson, Anne P., C. H. J. Ford, C.E. Newman, & Anthony Howell. (1984). A comparison of three assays used for the in vitro chemosensitivity testing of human tumours. British Journal of Cancer. 49(1). 57–63. 21 indexed citations
14.
Ford, C. H. J., et al.. (1981). Carcinoembryonic antigen and prognosis after radical surgery for lung cancer: Immunocytochemical localization and serum levels. British Journal of Cancer. 44(2). 145–153. 48 indexed citations
15.
Johnson, James R., C. H. J. Ford, C.E. Newman, et al.. (1981). A vindesine-anti-CEA conjugate cytotoxic for human cancer cells in vitro. British Journal of Cancer. 44(3). 472–475. 21 indexed citations
16.
Newman, C.E., C. H. J. Ford, & J. A. Jordan. (1980). Ovarian cancer : proceedings of the International Symposium on Ovarian Cancer, Birmingham, 24-25 September 1979. Pergamon Press eBooks. 1 indexed citations
17.
Newman, C.E., et al.. (1978). Preparation and characterization of an antiserum to cultured human oat-cell carcinoma cells. British Journal of Cancer. 37(5). 780–785. 2 indexed citations
18.
Ford, C. H. J., et al.. (1977). Roole of carcinoembryonic antigen in bronchial carcinoma.. Thorax. 32(5). 582–588. 8 indexed citations
19.
Elves, Michael W. & C. H. J. Ford. (1976). A study of the humoral immune response to massive osteoarticular allografts in sheep. Clinical & Experimental Immunology. 23(2). 360. 3 indexed citations
20.
Ford, C. H. J.. (1975). GENETIC STUDIES OF SHEEP LEUCOCYTE ANTIGENS. International Journal of Immunogenetics. 2(1). 31–40. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H.H. Sedlacek Breakdown of academic impact, for papers by Jen Wei Chiao Breakdown of academic impact, for papers by Bertil Björklund Breakdown of academic impact, for papers by William B. McCombs Breakdown of academic impact, for papers by Bing Zheng Breakdown of academic impact, for papers by Huili Lu Breakdown of academic impact, for papers by Jenny J. L. Ho Breakdown of academic impact, for papers by Carolyn Lyftogt Breakdown of academic impact, for papers by Marc Nasoff Breakdown of academic impact, for papers by Krzysztof Grzegorzewski
Rankless by CCL
2026